MAPT and Cognitive impairment: While Parkinson’s disease mimics had more amyloid-β and less tau deposition than typical MSA cases (Table 1), we did not identify any difference in the prevalence of cognitive impairment when compared between typical MSA and Parkinson’s disease mimic.